AW5-43467-58188
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 852 / AZ
- Registered
- 2021-10-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-15
Dose 1 — Pfizer-BioNTech
-
2021-10-16
Registered in v-safe
- 2021-10-17
-
2021-10-18
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Sneezing — Feeling: Fair · Fatigue or tirednessFree text: Nose congestion/sneezingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-20
- 2021-10-29
-
2021-11-05
Dose 2 — Pfizer-BioNTech
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-11
- 2021-11-12
- 2021-11-21
- 2021-11-28
- 2021-12-12
- 2021-12-17
- 2022-02-04
- 2022-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-15 | Pfizer-BioNTech | No |
| 2 | 2021-11-05 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Nose congestion/sneezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release